HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Radioprotector indralin at early and late manifestations of local radiation injuries.

Abstract
Experimental model of acute local radiation injuries (LRI) was the degree of radiation skin burns of mouse paws, observed through the 10 day within 1 month after local γ -60Co-irradiation at the doses of 20-45 Gy. For late local radiation injuries with a maximum of over 6 months after exposure to radiation, model was the contracture of animal paws and post-radiation amputation of limbs of the mouse. In the experiments on mice radioprotector indralin (B-190) IP as direct α1-adrenomimetic has a expressed protective effect on reducing acute and late LRI, equal in terms of dose reduction factor (DRF) 1.4 -1.5 that was comparable to their efficacy during radiation injuries of hematopoietic tissues. Indralin fully retain its radioprotective properties (DRF = 1.5-1.7) in the condition of repeated radioprotector administration through one day at total dose of 57 Gy (three times 19 Gy) of fractionated γ -irradiation. The protective effect of indralin improved at parenteral administration in the place of local irradiation. The local topical application of indralin in the ointments or in solution of dimethylsulfoxide has radioprotective effect, equal in the term of DRF to 1.3 -1.5 at acute and late LRI. Indralin also possessed a expressed radioprotective properties (DRF = 1.5) in decrease radiation injuries of salivary glands during local irradiation of head of rats.
AuthorsM M Vasin, I B Ushakov, V Y Kovtun
JournalVoprosy onkologii (Vopr Onkol) 2016 Vol. 62 Issue 3 Pg. 406-12 ISSN: 0507-3758 [Print] Russia (Federation)
PMID30462902 (Publication Type: Journal Article, Review)
Chemical References
  • Adrenergic Agonists
  • Phenols
  • Radiation-Protective Agents
  • indralin
  • Proteasome Endopeptidase Complex
Topics
  • Adrenergic Agonists (therapeutic use)
  • Animals
  • Dose Fractionation, Radiation
  • Gene Expression Regulation, Neoplastic (radiation effects)
  • Mice
  • Phenols (therapeutic use)
  • Proteasome Endopeptidase Complex (radiation effects)
  • Radiation Injuries (pathology, prevention & control)
  • Radiation-Protective Agents (therapeutic use)
  • Rats

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: